Christopher M. Yea

2021

In 2021, Christopher M. Yea earned a total compensation of $1.4M as Chief Development Officer at Carbylan Therapeutics, a 52% increase compared to previous year.

Compensation breakdown

Bonus$252,000
Option Awards$712,060
Salary$420,000
Other$25,341
Total$1,409,401

Yea received $712.1K in option awards, accounting for 51% of the total pay in 2021.

Yea also received $252K in bonus, $420K in salary and $25.3K in other compensation.

Rankings

In 2021, Christopher M. Yea's compensation ranked 7,519th out of 12,415 executives tracked by ExecPay. In other words, Yea earned more than 39.4% of executives.

ClassificationRankingPercentile
All
7,519
out of 12,415
39th
Division
Manufacturing
3,310
out of 5,505
40th
Major group
Chemicals And Allied Products
1,465
out of 2,375
38th
Industry group
Drugs
1,305
out of 2,096
38th
Industry
Pharmaceutical Preparations
961
out of 1,546
38th
Source: SEC filing on August 14, 2023.

Yea's colleagues

We found two more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2021.

2021

T Crockett

Carbylan Therapeutics

Chief Executive Officer

2021

Benjamin Palleiko

Carbylan Therapeutics

Chief Financial Officer

News

In-depth

You may also like